Although high expression of CCR7 in tumor cells is related to EMT and sorafenib resistance, however, a higher CCR7 expression was also found in mesenchymal sites in HCC (Fig. 1e), which was often involved in the infiltration of CCR7+ immune cells. Here, CCR7 is linked to neoplasm.